Pradaxa vs. Coumadin

See how Pradaxa and Coumadin compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Pradaxa is a fixed twice-daily dose with no routine blood testing, while Coumadin is a once-daily dose adjusted using regular INR blood tests.

  • Both drugs lower stroke risk in atrial fibrillation and treat blood clots, but only Coumadin is approved for people with mechanical heart valves.

  • Coumadin has decades of use and a much lower typical list price, while Pradaxa has fewer diet and drug interactions but costs more out of pocket.

Pradaxa vs. Coumadin Drug Summary

Pradaxa

Pradaxa (dabigatran) is a direct thrombin inhibitor, a newer class of blood thinner that does not require routine blood testing. It is FDA-approved to lower stroke risk in atrial fibrillation, to treat and prevent recurrent blood clots (DVT and PE), and to prevent clots after hip replacement surgery. It is a capsule taken twice daily at a fixed dose based on kidney function.

Coumadin

Coumadin (warfarin) is a vitamin K antagonist, one of the oldest blood thinners still widely prescribed. It is FDA-approved to treat and prevent blood clots, lower stroke risk in atrial fibrillation, and protect people with mechanical heart valves. It is a tablet taken once daily, with the dose adjusted based on regular blood tests.

Pradaxa vs. Coumadin Side Effects

Pradaxa

Most common
GI adverse reactions (up to 35%)
Dyspepsia (up to 7.5%)
GI bleeding (up to 6.6%)
Gastritis symptoms (up to 3%)

Coumadin

Most common
Hemorrhage (not specified as percentage on label)
Nausea (not specified as percentage on label)
Vomiting (not specified as percentage on label)
Diarrhea (not specified as percentage on label)

Pradaxa vs. Coumadin Dosage

Pradaxa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 150 mg twice daily At the start
Maximum dose 75 mg twice daily If needed
Dose changes 1 increase As tolerated

Coumadin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2 to 5 mg once daily Days 1-5
Maximum dose 2 to 5 mg once daily Same as starting
Dose changes None Fixed dose

Pradaxa vs. Coumadin Indications

Pradaxa

Pradaxa is approved to lower stroke risk in people with nonvalvular atrial fibrillation, and to treat or reduce the risk of recurrent deep vein thrombosis and pulmonary embolism. It is also approved to prevent blood clots after hip replacement surgery. It is not recommended for people with mechanical heart valves.

  • Reduce stroke and systemic embolism risk in nonvalvular AFib

  • Treat deep vein thrombosis and pulmonary embolism

  • Reduce risk of recurrent DVT or PE

  • Prevent DVT and PE after hip replacement surgery

Coumadin

Coumadin is approved to treat and prevent venous blood clots and pulmonary embolism, and to lower stroke risk in atrial fibrillation. It is also approved for people with mechanical heart valves and to reduce the risk of death or another heart attack after a myocardial infarction. It has been used for these purposes for over 70 years.

  • Treat and prevent venous thrombosis and pulmonary embolism

  • Reduce stroke risk in atrial fibrillation

  • Prevent clots in mechanical heart valves

  • Reduce death and recurrent MI risk after a heart attack

Pradaxa vs. Coumadin Pros and Cons

Pradaxa

Pradaxa avoids the routine blood draws and dietary restrictions that come with warfarin, and has a specific reversal agent for emergencies. It costs significantly more than warfarin without insurance and is not an option for people with mechanical heart valves.

Pros

  • No routine blood testing needed to guide dosing

  • Few food interactions; dietary vitamin K does not affect it

  • Specific reversal agent (idarucizumab) available for emergencies

  • Fixed dosing not affected by genetic differences in metabolism

Cons

  • Costs roughly $400 to $530 per month brand-name, without insurance

  • Not recommended for people with mechanical heart valves

  • Must be taken twice a day, every day, without missed doses

  • Dose must be adjusted or avoided with significant kidney impairment

Coumadin

Coumadin requires regular INR blood tests and careful attention to vitamin K intake and other drug interactions to stay in a safe range. It is inexpensive and has decades of real-world use, and remains the standard oral option for mechanical heart valves.

Pros

  • Roughly $40 to $100 per month without insurance, much cheaper than Pradaxa

  • Approved for people with mechanical heart valves

  • Decades of clinical experience across many patient types

  • Effect can be reversed with vitamin K if needed

Cons

  • Requires regular blood draws to monitor INR levels

  • Many food and drug interactions, especially vitamin K-rich foods

  • Genetic differences can make dosing harder to predict

  • Narrow safe range between too little and too much drug

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.